2022
DOI: 10.1016/j.xhgg.2022.100107
|View full text |Cite|
|
Sign up to set email alerts
|

Identification and validation of candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(12 citation statements)
references
References 54 publications
(71 reference statements)
1
11
0
Order By: Relevance
“…Using genome sequencing, we recently established a cohort of 185 EA/TEF patients who were enriched for potentially damaging and missense de novo heterozygous variants in genes involved in intracellular transport and endocytosis (Zhong et al, 2022). An analysis of known protein-protein interactions from the STRING database (Szklarczyk et al, 2023) revealed that many of the proteins encoded by patient risk genes interact with core recycling endosome trafficking components (Figure 1A), supporting evidence that this pathway has an important role in trachea-esophageal morphogenesis (Nasr et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Using genome sequencing, we recently established a cohort of 185 EA/TEF patients who were enriched for potentially damaging and missense de novo heterozygous variants in genes involved in intracellular transport and endocytosis (Zhong et al, 2022). An analysis of known protein-protein interactions from the STRING database (Szklarczyk et al, 2023) revealed that many of the proteins encoded by patient risk genes interact with core recycling endosome trafficking components (Figure 1A), supporting evidence that this pathway has an important role in trachea-esophageal morphogenesis (Nasr et al, 2019).…”
Section: Resultsmentioning
confidence: 99%
“…Damaging variants in these genes all involved in endosome trafficking are suggestive of a pathway-related syndrome, or an endosomeopathy, that may underlie the pathogenesis of EA/TEF. Endosome trafficking may be required in multiple organs to facilitate tissue and cell organization and may underlie why EA/TEF patients with variants in endosome trafficking genes often present with co-morbidities including neurodevelopmental disorders and congenital anomalies in other organs (Zhong et al, 2022). Comorbidities may manifest due to disruptions of endosome trafficking in other fusing and septating organs like the neural tube, palate, urogenital septum, and the heart.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…They also described candidate genes like TCF4 and NRXN1 as having sufficient evidence to support an association with EA/TEF and others like NSD1, PTPN11, and FLNA with insufficient evidence to support association [12]. Another large study by Zhong et al performed whole genome sequencing on 185 trios that included 59 isolated and 126 complex cases and found a significant burden of protein-altering de-novo coding variants in the complex cases although many were classified as VUS [24]. They concluded that the number of risk genes contributing is very large, highlighting the genetic heterogeneity of EA/TEF.…”
Section: Discussionmentioning
confidence: 99%